NUNNELLY JOHN N 4

What Happened

• John Nunnelly, a director of NRC Health (NRC), was granted 7,697 restricted stock units (RSUs) on June 23, 2026. The Form 4 shows an acquisition at $0.00 per share (code A — award/grant); the award was granted as part of annual equity compensation and is described in the filing as having a grant value of $150,000.

Key Details

• Transaction date: 2026-06-23; Form 4 filed: 2026-06-25 (appears timely under Form 4 rules).
• Shares/units granted: 7,697 RSUs; reporting price on the Form 4: $0.00 (award); grant value per filing: $150,000 (see footnote).
• Vesting: The RSUs will vest and become exercisable on the date of the Issuer’s 2027 annual stockholder meeting, subject to forfeiture and termination provisions.
• Plan: Award made under the Issuer's 2025 Omnibus Incentive Plan.
• Shares owned after the transaction: not specified in the filing.
• Filing footnote: The award equals $150,000 divided by the closing price on the day before the 2026 annual meeting (resulting in 7,697 RSUs).

Context

• This was a compensation grant (award), not an open-market purchase or sale. Such grants are routine director compensation and vest over time; they do not represent an immediate cash inflow or market sale.
• For investors, purchases or open-market sales can be stronger signals of insider sentiment; awards primarily reflect compensation policy and retention incentives rather than a direct trading view.